Irie RF - Search Results

1

Human monoclonal antibody identified an immunoreactive tetrapeptide sequence (Lys-Tyr-Gln-Ile) in M(r) 43,000 protein of human melanoma.

Oka T, Kikumoto Y, Itakura K, Morton DL, Irie RF. Oka T, et al. Among authors: irie rf. Cancer Res. 1994 Jul 1;54(13):3511-5. Cancer Res. 1994. PMID: 8012974

2

Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma.

Irie RF, Ollila DW, O'Day S, Morton DL. Irie RF, et al. Cancer Immunol Immunother. 2004 Feb;53(2):110-7. doi: 10.1007/s00262-003-0436-1. Epub 2003 Oct 16. Cancer Immunol Immunother. 2004. PMID: 14564483 Free PMC article. Clinical Trial.

3

Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.

Hoon DS, Banez M, Okun E, Morton DL, Irie RF. Hoon DS, et al. Among authors: irie rf. Cancer Res. 1991 Apr 15;51(8):2002-8. Cancer Res. 1991. PMID: 1901239

4

Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas.

Hoon DS, Okun E, Banez M, Irie RF, Morton DL. Hoon DS, et al. Among authors: irie rf. Cancer Res. 1991 Oct 15;51(20):5687-93. Cancer Res. 1991. PMID: 1913686

5

Ganglioside GM3:GD3 ratio as an index for the management of melanoma.

Ravindranath MH, Tsuchida T, Morton DL, Irie RF. Ravindranath MH, et al. Among authors: irie rf. Cancer. 1991 Jun 15;67(12):3029-35. doi: 10.1002/1097-0142(19910615)67:12<3029::aid-cncr2820671217>3.0.co;2-8. Cancer. 1991. PMID: 2044049

6

An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.

Ravindranath MH, Morton DL, Irie RF. Ravindranath MH, et al. Among authors: irie rf. Cancer Res. 1989 Jul 15;49(14):3891-7. Cancer Res. 1989. PMID: 2472199

7

Human monoclonal antibodies: prospects for the therapy of cancer.

Wong JH, Irie RF, Morton DL. Wong JH, et al. Among authors: irie rf. Semin Surg Oncol. 1989;5(6):448-52. doi: 10.1002/ssu.2980050612. Semin Surg Oncol. 1989. PMID: 2556770 Review.

8

Ganglioside GM2 expression on human melanoma cells correlates with sensitivity to lymphokine-activated killer cells.

Hoon DS, Ando I, Sviland G, Tsuchida T, Okun E, Morton DL, Irie RF. Hoon DS, et al. Among authors: irie rf. Int J Cancer. 1989 May 15;43(5):857-62. doi: 10.1002/ijc.2910430520. Int J Cancer. 1989. PMID: 2714890

9

Gangliosides of human melanoma.

Tsuchida T, Saxton RE, Morton DL, Irie RF. Tsuchida T, et al. Among authors: irie rf. Cancer. 1989 Mar 15;63(6):1166-74. doi: 10.1002/1097-0142(19890315)63:6<1166::aid-cncr2820630621>3.0.co;2-5. Cancer. 1989. PMID: 2917320

10

A decapeptide (Gln-Asp-Leu-Thr-Met-Lys-Tyr-Gln-Ile-Phe) from human melanoma is recognized by CTL in melanoma patients.

Morioka N, Kikumoto Y, Hoon DS, Morton DL, Irie RF. Morioka N, et al. Among authors: irie rf. J Immunol. 1994 Dec 15;153(12):5650-8. J Immunol. 1994. PMID: 7527447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters